Update on the management of pelvic inflammatory disease.
10.5468/kjog.2010.53.11.961
- Author:
Moon Kyoung CHO
1
Author Information
1. Department of Obstetrics and Gynecology, Chonnam National University Medical School, Gwangju, Korea. chomk@chonnam.ac.kr
- Publication Type:Review
- Keywords:
Pelvic inflammatory disease;
Antibiotics;
Pathogen
- MeSH:
Anti-Bacterial Agents;
Female;
Humans;
Hypogonadism;
Infertility;
Inflammation;
Mitochondrial Diseases;
Ophthalmoplegia;
Pelvic Inflammatory Disease;
Pelvic Pain;
Pregnancy;
Pregnancy, Ectopic;
Quinolones
- From:Korean Journal of Obstetrics and Gynecology
2010;53(11):961-966
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pelvic inflammatory disease (PID), the infection and inflammation of a woman's upper genital tract, is a frequent cause of infertility, ectopic pregnancy, and chronic pelvic pain among women of childbearing age. The management of PID has been largely based on the protocols issued by national or international institution. These guidelines recommended a broad-spectrum antibiotherapy in which quinolones continue to hold a key place. Yet, several significant facts such as the increase of quinolone-resistant gonococci and the emergence of 'new' pathogens have recently led us to reconsider the paradigms of the management of PID. This article reviewed lately published literatures on new bacteriological finding and recent antibiotics trials to delinate optimal regimen in managing PID.
